Healthcare

Baillie Gifford scored a gain of $27.6 billion by betting early on Moderna, Tesla and Alibaba. Its team breaks down the 3-part strategy it uses to discover transformational stocks that offer…

Edinburgh-based firm Baillie Gifford took early bets in some of last year’s biggest winners. Tesla, Moderna and Alibaba have made the firm profits of around $27.6 billion – Bloomberg data. The Baillie Gifford team told Insider their 3 tips to making a success of active investing. Visit the Business section of Insider for more stories. … Read more

Why stock prices decline when you buy and increase when you sell ?

Is there any logical explanation to this? I think there is – checkout if it makes sense.

Blackstone, Partners Group Holding in race to acquire Piramal Glass

The investment firms have progressed to the final round of bidding for India’s Piramal Glass, the people said, asking not to be identified as the information is private. Billionaire Ajay Piramal’s conglomerate is seeking a valuation of $1 billion for the unit from the sale, the people said. Piramal could name a winner as soon … Read more

Capital International buys bulk of Analjit Singh’s stake in Max Healthcare

London-based wealth management giant Capital International Group on Friday bought 4.6% stake from Max group’s founder Analjit Singh in Max Healthcare for around ₹515 crore. Two persons aware of the development confirmed this, adding that proceeds from the stake sale by Singh will primarily be used for paying off the debts that Singh owes in … Read more

Stocks: When to sell? – Part 1

The most difficult and confusing topic in stock investing !

COVID2019 and stock investing – Part 4 – is it a blessing in disguise for the Indian economy !

At first read, the presented arguments may sound counter intuitive. However, think carefully and you might agree.

First liquid biopsy to receive FDA Approval for comprehensive tumor profiling across all solid cancers, Guardant Health’s Guardant360® CDx, gains credibility among oncologists in Asia, Middle East…

The U.S. Food and Drug Administration (FDA) has approved Guardant Health’s liquid biopsy, Guardant360® CDx, for tumor mutation profiling in patients across all solid cancers. For Guardant Health Asia, Middle East and Africa (AMEA), this FDA approval represents a landmark achievement of the Guardant360 test. Currently, the liquid biopsy is commercially available in 41 countries in … Read more

Eli Lilly Covid-19 treatment could be authorised by September: Chief Scientist

If all goes well with either of two antibody therapies it is testing. Lilly is also doing preclinical studies of a third antibody treatment for the illness caused by the new coronavirus that could enter human clinical trials in the coming weeks, Chief Scientific Officer Daniel Skovronsky said in an interview. Lilly has already launched … Read more

AstraZeneca eyes record pharma merger with Gilead

The UK-based firm informally contacted Gilead last month to gauge its interest in a possible tie-up, the people said, asking not to be identified because the details are private. AstraZeneca didn’t specify terms for any transaction, they said. While Gilead has discussed the idea with advisers, no decisions have been made on how to proceed … Read more